Inhibition of androgen-sensitive LNCaP prostate cancer growth in vivo by melatonin: association of antiproliferative action of the pineal hormone with mt1 receptor protein expression

scientific article

Inhibition of androgen-sensitive LNCaP prostate cancer growth in vivo by melatonin: association of antiproliferative action of the pineal hormone with mt1 receptor protein expression is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/1097-0045(200101)46:1<52::AID-PROS1008>3.0.CO;2-Z
P698PubMed publication ID11170132

P2093author name stringShiu SY
Fong SW
Siu SW
Xi SC
P433issue1
P921main subjectmelatoninQ180912
prostate cancerQ181257
P304page(s)52-61
P577publication date2001-01-01
P1433published inThe ProstateQ7758608
P1476titleInhibition of androgen-sensitive LNCaP prostate cancer growth in vivo by melatonin: association of antiproliferative action of the pineal hormone with mt1 receptor protein expression
P478volume46

Reverse relations

cites work (P2860)
Q28537709Characterization of chemically induced ovarian carcinomas in an ethanol-preferring rat model: influence of long-term melatonin treatment
Q36083886Circadian disruption, sleep loss, and prostate cancer risk: a systematic review of epidemiologic studies
Q36554668Expression of melatonin receptors in triple negative breast cancer (TNBC) in African American and Caucasian women: relation to survival
Q36282807Functional MT1 and MT2 melatonin receptors in mammals
Q39538005Functional interplay between melatonin receptor-mediated antiproliferative signaling and androgen receptor signaling in human prostate epithelial cells: potential implications for therapeutic strategies against prostate cancer.
Q38851907HDAC1 inhibition by melatonin leads to suppression of lung adenocarcinoma cells via induction of oxidative stress and activation of apoptotic pathways
Q35947279Influence of Melatonin on the Proliferative and Apoptotic Responses of the Prostate under Normal and Hyperglycemic Conditions.
Q38683029Inherited variation in circadian rhythm genes and risks of prostate cancer and three other cancer sites in combined cancer consortia
Q92212328Inhibition of autophagy triggers melatonin-induced apoptosis in glioblastoma cells
Q24623433International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors
Q28083929MT1 and MT2 Melatonin Receptors: A Therapeutic Perspective
Q82240414Melatonin
Q55065118Melatonin Analogue Antiproliferative and Cytotoxic Effects on Human Prostate Cancer Cells.
Q34554008Melatonin Induces Apoptotic Cell Death via p53 in LNCaP Cells
Q38754474Melatonin Inhibits Androgen Receptor Splice Variant-7 (AR-V7)-Induced Nuclear Factor-Kappa B (NF-κB) Activation and NF-κB Activator-Induced AR-V7 Expression in Prostate Cancer Cells: Potential Implications for the Use of Melatonin in Castration-Resi
Q39303608Melatonin MT1 receptor-induced transcriptional up-regulation of p27(Kip1) in prostate cancer antiproliferation is mediated via inhibition of constitutively active nuclear factor kappa B (NF-κB): potential implications on prostate cancer chemoprevent
Q44059675Melatonin and prostate cancer cell proliferation: interplay with castration, epidermal growth factor, and androgen sensitivity
Q99565353Melatonin and urological cancers: a new therapeutic approach
Q44380584Melatonin inhibits growth of diethylstilbestrol-induced prolactin-secreting pituitary tumor in vitro: possible involvement of nuclear RZR/ROR receptors
Q37088995Melatonin represses oxidative stress-induced activation of the MAP kinase and mTOR signaling pathways in H4IIE hepatoma cells through inhibition of Ras.
Q33624824Melatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis
Q35153727Natural products for cancer prevention: a global perspective
Q36839618Sleep disruption among older men and risk of prostate cancer
Q33399301The efficacy and safety of melatonin in concurrent chemotherapy or radiotherapy for solid tumors: a meta-analysis of randomized controlled trials
Q36872043Towards rational and evidence-based use of melatonin in prostate cancer prevention and treatment.
Q28077467WOMEN IN CANCER THEMATIC REVIEW: Circadian rhythmicity and the influence of 'clock' genes on prostate cancer

Search more.